Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition

Nature Methods

Volumn 10, Issue 12, 2013, Pages 1239-1245

  Lambert, Jean Philippe ^a   Ivosev, Gordana ^b   Couzens, Amber L ^a   Larsen, Brett ^a   Taipale, Mikko ^c   Lin, Zhen Yuan ^a   Zhong, Quan ^d,e   Lindquist, Susan ^c,f,g   Vidal, Marc ^d,e   Aebersold, Ruedi ^h,i   Pawson, Tony ^a,j   Bonner, Ron ^b   Tate, Stephen ^b   Gingras, Anne Claude ^a,j  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MDS SCIEX   (Canada)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h ETH ZURICH   (Switzerland)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; LUMINESPIB; MELANOMA ANTIGEN; TETRACYCLINE;

AFFINITY PURIFICATION; ARTICLE; AUTOMATION; COMPLEX FORMATION; CONTROLLED STUDY; COST; CROSS COUPLING REACTION; DATA EXTRACTION; DRUG DETERMINATION; GENE MUTATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PEPTIDE MAPPING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; SEQUENTIAL WINDOW ACQUISITION OF ALL THEORETICAL SPECTRA; STATISTICAL ANALYSIS; SYSTEMS BIOLOGY;

AUTOMATION; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; CYCLIN-DEPENDENT KINASE 4; GENE LIBRARY; HUMANS; ISOXAZOLES; MASS SPECTROMETRY; MUTATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN INTERACTION MAPPING; PROTEINS; RESORCINOLS; SYSTEMS BIOLOGY;

EID: 84888871108     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.2702     Document Type: Article

References (43)

1. Barrios-Rodiles, M. et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307, 1621-1625 (2005). (Pubitemid 40354744)
2. Delmore, J.E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917 (2011).
3. Vacic, V. & Iakoucheva, L.M. Disease mutations in disordered regions-exception to the rule? Mol. Biosyst. 8, 27-32 (2012).
4. Steward, R.E., MacArthur, M.W., Laskowski, R.A. & Thornton, J.M. Molecular basis of inherited diseases: a structural perspective. Trends Genet. 19, 505-513 (2003). (Pubitemid 37101091)
5. Lahiry, P., Torkamani, A., Schork, N.J. & Hegele, R.A. Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat. Rev. Genet. 11, 60-74 (2010).
6. Schuster-Böckler, B. & Bateman, A. Protein interactions in human genetic diseases. Genome Biol. 9, R9 (2008).
7. Zhong, Q. et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 5, 321 (2009).
8. Gingras, A.C., Gstaiger, M., Raught, B. & Aebersold, R. Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol. 8, 645-654 (2007). (Pubitemid 47106612)
9. Ideker, T. & Krogan, N.J. Differential network biology. Mol. Syst. Biol. 8, 565 (2012).
10. Gingras, A.C. & Raught, B. Beyond hairballs: the use of quantitative mass spectrometry data to understand protein-protein interactions. FEBS Lett. 586, 2723-2731 (2012).
11. Tabb, D.L. et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 9, 761-776 (2010).
12. Tate, S., Larsen, B., Bonner, R. & Gingras, A.C. Label-free quantitative proteomics trends for protein-protein interactions. J. Proteomics 81, 91-101 (2013).
13. Bisson, N. et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat. Biotechnol. 29, 653-658 (2011).
14. Zheng, Y. et al. Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166-171 (2013).
15. Picotti, P. & Aebersold, R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 9, 555-566 (2012).
16. Addona, T.A. et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27, 633-641 (2009).
17. Venable, J.D., Dong, M.Q., Wohlschlegel, J., Dillin, A. & Yates, J.R. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 1, 39-45 (2004).
18. Gillet, L.C. et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, O111.016717 (2012).
19. Liu, Y. et al. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13, 1247-1256 (2013).
20. Collins, B.C. et al. Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat. Methods doi:10.1038/nmeth.2703 (27 October 2013).
21. Andrews, G.L., Simons, B.L., Young, J.B., Hawkridge, A.M. & Muddiman, D.C. Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). Anal. Chem. 83, 5442-5446 (2011).
22. Kean, M.J., Couzens, A.L. & Gingras, A.C. Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods 57, 400-408 (2012).
23. Gingras, A.C., Raught, B. & Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913-963 (1999). (Pubitemid 29449212)
24. Yang, H.S. et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 23, 26-37 (2003).
25. Jeronimo, C. et al. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol. Cell 27, 262-274 (2007). (Pubitemid 47058308)
26. Wölfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281-1284 (1995).
27. Zuo, L. et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12, 97-99 (1996). (Pubitemid 26013159)
28. Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707 (1993). (Pubitemid 24036021)
29. Coleman, K.G. et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem. 272, 18869-18874 (1997). (Pubitemid 27318237)
30. Shimamura, T., Lowell, A.M., Engelman, J.A. & Shapiro, G.I. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res. 65, 6401-6408 (2005). (Pubitemid 40994428)
31. Grbovic, O.M. et al. V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors. Proc. Natl. Acad. Sci. USA 103, 57-62 (2006). (Pubitemid 43076104)
32. Taipale, M. et al. Quantitative analysis of Hsp90-client interactions reveals principles of substrate recognition. Cell 150, 987-1001 (2012).
33. Prodromou, C. Strategies for stalling malignancy: targeting cancer's addiction to Hsp90. Curr. Top. Med. Chem. 9, 1352-1368 (2009).
34. Brough, P.A. et al. 4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J. Med. Chem. 51, 196-218 (2008).
35. Taipale, M., Jarosz, D.F. & Lindquist, S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11, 515-528 (2010).
36. da Rocha Dias, S. et al. Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 65, 10686-10691 (2005).
37. Liu, G. et al. ProHits: integrated software for mass spectrometry-based interaction proteomics. Nat. Biotechnol. 28, 1015-1017 (2010).
38. Mellacheruvu, D. et al. The CRA Pome: a contaminant repository for affinity purification-mass spectrometry data. Nat. Methods 10, 730-736 (2013).
39. Dunham, W.H. et al. A cost-benefit analysis of multidimensional fractionation of affinity purification-mass spectrometry samples. Proteomics 11, 2603-2612 (2011).
40. Luke-Glaser, S. et al. CIF-1, a shared subunit of the COP9/signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-26 levels in the Caenorhabditis elegans embryo. Mol. Cell. Biol. 27, 4526-4540 (2007). (Pubitemid 46906574)
41. Shilov, I.V. et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655 (2007). (Pubitemid 47506173)
42. Reiter, L. et al. mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8, 430-435 (2011).
43. Bolstad, B.M., Irizarry, R.A., Astrand, M. & Speed, T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003). (Pubitemid 36181903)